ArriVent BioPharma, Inc.
AVBP
$29.79
-$0.49-1.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.31% | 85.36% | 42.93% | 6.16% | -21.09% |
| Total Receivables | -- | -- | -- | 1.00% | -32.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 45.87% | 16.90% | -54.30% | -51.62% | -35.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 51.15% | 161.82% | 175.91% | 151.77% | 67.41% |
| Total Current Assets | 57.58% | 87.69% | 46.66% | 9.86% | -18.92% |
|
|
|||||
| Total Current Assets | 57.58% | 87.69% | 46.66% | 9.86% | -18.92% |
| Net Property, Plant & Equipment | 335.29% | 208.33% | -91.56% | -73.80% | -61.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -63.47% | 27.84% | 105.56% | 42.86% | 283.20% |
| Total Assets | 46.46% | 62.09% | 21.18% | 11.56% | -12.74% |
|
|
|||||
| Total Accounts Payable | -45.39% | 99.98% | 56.90% | 27.70% | 6.51% |
| Total Accrued Expenses | 63.52% | 91.33% | 50.02% | 50.29% | 90.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 224.49% | -28.26% | -91.36% | -64.33% | -35.53% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 41.80% | 92.97% | 50.20% | 42.18% | 62.31% |
|
|
|||||
| Total Current Liabilities | 41.80% | 92.97% | 50.20% | 42.18% | 62.31% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 41.97% | 95.44% | 50.08% | 41.66% | 61.00% |
|
|
|||||
| Common Stock & APIC | 48.11% | 52.83% | 43.46% | 36.09% | 18.27% |
| Retained Earnings | -49.00% | -47.98% | -69.78% | -69.54% | -69.49% |
| Treasury Stock & Other | -1,383.33% | -1,488.24% | 106.64% | -- | -- |
| Total Common Equity | 46.81% | 59.96% | 19.24% | 9.91% | -15.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.81% | 59.96% | 19.24% | 9.91% | -15.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.81% | 59.96% | 19.24% | 9.91% | -15.77% |
|
|
|||||